1/2 Today, we make Liquid State Intelligence (LSI) generally available for antibody development programmes.
LSI reads how a molecule behaves far from equilibrium, under the stresses of manufacture and delivery, from 8 µg at hit stage.
Watch our CEO @shamits walk through the platform below!
Next week at @WebSummit, our Founder & COO Anshika Srivastava joins and Asier Alea @bculinary and Alex Wiltschko @osmo_labs on the panel “Sensing the Future: Using AI to Unlock the Next Generation of Molecular Science”, moderated by @stokel.
Alex works on smell, Asier on taste. We work one layer down, on how matter itself behaves.
Anshika is in Lisbon on 10 Nov. If you’re building or writing about AI for the physical world, DM us to get in touch!
📍 Future of Work Summit, Stage 4, Web Summit Lisbon
🕚 10 Nov, 11:50 to 12:10
Five years ago, Alec Thomas became the first person to join Apoha’s founders full-time. Today he leads every campaign taking LSI into new territory, from oligos to emerging antibody formats.
Thank you for everything, Alec. Here’s to the next five 🥂
It would be great to replicate this study on our LSI platform (https://t.co/nJWuzaoKfl) that directly measures physicochemical embeddings coupled to multiple properties simultaneously. Built for antibodies but the idea was indeed inspired by lipinski rule classification. Can we get our hands on the 700 molecules lying around by any chance. Would love to see how it compares to the methods and measures described in the post.
Physics and biology have spent decades studying the same world from different perspectives.
Physics looks for laws. The fewest assumptions, the broadest reach. It begins with macroscopic observations and works downward toward what must be true underneath.
Biology builds upward. From molecules to mechanisms to systems. Constructive, detailed, mechanistic.
Both are necessary. But the constructive direction has dominated modern molecular science. Start with the sequence. Predict the structure. Simulate the dynamics. Infer the behaviour.
That direction has produced extraordinary progress. It is also why we keep getting blindsided by behaviour we did not predict. A protein that aggregates in formulation. An antibody that fails in development. A lipid nanoparticle that behaves differently in vivo than in vitro.
The constructive path runs into a wall that physics has known about for over a century: complex systems are too coupled, too high-dimensional, and too sensitive to conditions to be fully derived from first principles.
When physics ran into that wall, it did something different. It defined the equation of state. A description of how matter behaves under real conditions, derived not from first principles but from observation. Gibbs gave it mathematical form. Maxwell sculpted one in clay. For 150 years, the equation of state has been how physics describes complex matter when first-principles derivation breaks down.
We have never had an equation of state for complex biology.
That is what we are building at Apoha. Liquid State Intelligence brings the equations-of-state tradition to proteins, formulations, and biological fluids. Instead of deriving behaviour from sequence and structure, we measure it directly, at interfaces, under controlled stresses, in real time.
It is not a rejection of the constructive path. It is the missing complement to it. The macroscopic anchor that lets the microscopic models converge on and collapse into what matter actually does.
💰 Apoha today emerges from stealth with $36M in funding. https://t.co/wi3P3IatCW It was led by Singular, with participation from Tim Draper’s @DraperVC and continued backing from seed investors @redalpine, @seedcamp, Wilbe and Nucleus, alongside grant funding from @innovateuk. #womenintech #femalefounders #uktech #startups #London #innovation #technology #funding #investment #vcfunding
Exclusive: Apoha, a startup building AI models for creating new materials, emerges from stealth with $36 million Series A funding round https://t.co/NCqOJBnpzo #AI#Pharma#Startups#Funding#Innovation
Apoha, which is developing a "Liquid State Intelligence" data layer to measure molecules in the real world, emerges from stealth with $36M led by Singular (@mikebutcher / Pathfounders)
(Visit Techmeme dot com for the link and full context!)
Apoha raised $36M for a different kind of AI-for-science wedge: not only better models, but a new measurement layer for how matter behaves.
The London and San Francisco startup closed a Series A led by Singular, with Draper Associates participating and Redalpine, Seedcamp, Wilbe, and Nucleus Capital continuing as seed investors. Apoha is building AI models for substances including proteins, food products, paints, drugs, and materials.
The core product is VIBE, a measurement system that suspends a tiny material sample in liquid, applies controlled physical stresses, and records the wave patterns that come back. Apoha turns those recordings into behavioral embeddings, giving models data about how a material behaves rather than only what it looks like or how it is described.
The early pharma signal is concrete. Apoha says a multi-year partnership with Boehringer Ingelheim showed the platform identifying high-risk antibody candidates with more than 90% precision from as little as 8 micrograms of material, and that a 236-antibody benchmark beat 12 industry-standard tests. LinkedIn also shows active open roles for Apoha.
Quick facts👇
● founders: Anshika Srivastava; Shamit Shrivastava
● total capital raised: at least $36M
● HQ: London and San Francisco
● Investors: Singular; Draper Associates; Redalpine; Seedcamp; Wilbe; Nucleus Capital
● Partners: Boehringer Ingelheim; Ethris; Somru BioSciences
The question is whether the next AI-for-science moat is less about model architecture and more about owning a data modality nobody else can measure at scale.
<p><a href="https://t.co/zayKvm00rf">Apoha</a>, a deep tech startup that is building AI models for creating new kinds of substances—from proteins to food products to paints—based on a new kind of data about how materials behave, is emerging from stealth today with $36 million in venture capital funding.<br><br>The funding round, which is the London- and San Francisco-based startup’s Series A, is being led by European venture capital firm Singular, with participation from Draper Associates and continued backing from existing seed investors Redalpine, Seedcamp, Wilbe, and Nucleus. The company also has a grant from Innovate UK, the U.K.’s national innovation agency.<br><br>The company did not disclose its valuation following the funding.</p>
<p>Apoha is betting that the key to unlocking many new kinds of materials rests in a kind of data that does not exist yet at scale: measurements of the wave forms these materials generate when suspended in a liquid and then acted on by outside forces. It turns out that these warm forms are unique to each material and also correlate to its properties, including qualities such as smell and taste, as well as things like reactivity. With enough of this wave data, Apoha’s AI models will be able to suggest ways to modify or create a material in order to obtain the exact characteristics a user desires. Apoha calls this new AI method “liquid intelligence.”</p>
<p>“Machines have learned to see what matter looks like and to read what we say about it,” <a href="https://t.co/AGRXm215Kd">Anshika Srivastava</a>, Apopha’s cofounder and chief operating officer, said. Many AI models are trained only on text or on image data. “They have not learned to taste, smell, or feel matter—to perceive how a drug dissolves, how a flavour holds, how a material wears. That is the layer we are building.”</p>
<p>Srivastava, a former Goldman Sachs banker, cofounded Apoha in 2021 alongside <a href="https://t.co/UMDK9VFnjv">Shamit Shrivastava</a>, a mechanical engineer who did post-doctoral research at the University of Oxford after completing a PhD at Boston University. Shrivastava, who is now Apoha’s CEO, pioneered the methods on which the company’s technology is based. He holds the patent on the liquid wave form analysis the company uses to create the data for its AI models as well as on many of the specialized hardware devices the company has had to create to carry out its experiments.</p>
<p>The company’s name comes from a Sanskrit word that means “negation or exclusion” and is part of Buddhist philosophy that things are defined by what they are <em>not</em> more than by what they are.</p>
<p>Apoha has built a piece of laboratory hardware that takes a sample of material so small it would fit on the head of a pin, suspends it in a liquid, and then applies a controlled series of tiny physical stresses to it. The device records the wave patterns that ripple back through the liquid in response. According to the company, those patterns yield more than 1,000 distinct numerical descriptors of how the material behaves, captured in a single run that takes minutes rather than the days or weeks conventional lab tests require.</p>
<p>That readout — which the company calls VIBE, short for Variations in Inter-facial Behaviour Under Excitation — is its first commercial product. Apoha then turns the raw recordings into what Shrivastava calls a “behavioral embedding,” a numerical fingerprint that AI models can be trained to recognize, compare and learn from.</p>
<p>The VIBE measurement, Apoha’s cofounders say, can predict whether a drug will hold together inside the body, whether a plant-based protein will tear apart on the tongue like chicken meat, or how a new material will wear over time. One Apoha’s first customers was a food company that had to find a substitute for the key component in its plant-based vegan “chicken” within two weeks after a previous supplier went out of business. </p>
<p>In pharma, the immediate use case is screening drug candidates before they enter expensive clinical trials. The company says a multi-year research partnership with German pharmaceutical firm <a href="https://t.co/m9J52GBDgX" target="_blank">Boehringer Ingelheim</a> has shown Apoha identifying high-risk antibody candidates with greater than 90% precision from as little as 8 micrograms of material. In a separate benchmark on a dataset of 236 antibodies that had reached clinical trials, the company says its platform outperformed 12 industry-standard tests pharma firms currently use to predict whether a drug will fail in patients. Catching such failures earlier could save drugmakers hundreds of millions of dollars per failed candidate, Apoha says.</p>
<p>Outside pharma, Apoha is working with German biotech Ethris on predicting how lipid nanoparticles carrying mRNA—the same kind of delivery vehicle used in some COVID-19 vaccines —will behave in animals. The startup also works with Somru BioSciences and what it describes as multiple Fortune 500 customers across pharma, food and beverage, and materials.</p>
<p>Apoha says it has completed a total of about 40 customer projects to date. The company has about 25 employees.</p>
<p>Srivastava said the Series A funds will go toward scaling Apoha’s platform—which includes custom hardware for carrying out the experiments needed to obtain the VIBE data, as well as the AI models built from the data—to handle more sample types and more customers.</p>
<p>Raffi Kamber, co-founder and general partner at Singular, said in a statement that Apoha represents “a new generation of European scientific companies where AI is not a future promise, but a practical tool already transforming how biology is done.”</p>
<p>This story was originally featured on <a href="https://t.co/gaVOiOIFu7" target="_blank">https://t.co/opgY7EYkBs</a></p> https://t.co/gaVOiOIFu7
A London startup today stepped out of stealth with a big idea and the money to chase it. Apoha raised $36 million in a Series A led by Singular with Draper Associates joining in. Fortune
much of AI today reads text and code. Apoha wants machines to understand the physical world. It measures how molecules and materials actually behave under real world stress then turns that into data AI can learn from. They call it liquid state intelligence.
Their first tool, VIBE, takes a sample small enough to sit on a pinhead, drops it in liquid, pokes it and reads the wave patterns it gives back. One reading captures over 1,000 measurements, where old methods test one thing at a time. The Next Web
The city pulled in $4.2 billion of deep tech money this year, more than Paris and Berlin https://t.co/nbCNeH1Sze is becoming Europe's lab.
Congrats @Shamits n Anshika Srivastava
Great to interview Apoha founders. Podcast coming soon! (Have to say that as a journalist who now also does social and podcasts, as well as writing, @sxswlndn is way better set up than @LDNTechWeek. Last year LTW had a tiny windowless room for press, and no podcast facilities….)
I’m thrilled to announce we’ve raised $44M to build a new home for product design. Meet @noondesign.
No workflow is more broken and fragmented in 2026 than the product designers’. The very same people who care most about building software don’t have software purpose built for them. @kushagrasinha7 and I have lived this problem first hand as designers ourselves.
That’s why we built Noon. The first product design tool that works entirely on your product code, so you can design not only how a product looks, but also how it works. With AI at its core that works in seconds, not minutes.
For the first time, you can create, iterate, build, test and ship. All in one canvas. No translations or roundtrips to the codebase and back.
Comment “Get Noon” and we’ll get you on the list for early access.
It’s a well established idea in reservoir computing and echostate network. More over it leads to in the interesting possibilities of using physical phenomena that are naturally capable of such transformation like splash in a pool of water as natural substrates for computing, the very idea my company is based on :) happy to chat more
Indeed command level data is the context layer for instruments about the process that generated what we consume as response data. Every measurement is a response function of a scientific instrument, what today’s instrument not capture well is the input. A peak in HPLC is completely context dependent which includes minor fluctuations in flow rate for example. This is AI first thinking for scientific instruments and we are building a new one at Apoha - that we call liquid brain.
We are generating a new kind of behaviorial data on proteins based on a so called silly scientific idea that we call a aliquid brain, ability of primordial soup to sense and process materials behavior. Let me know if interested in trying out our clinical antibody dataset of 200+ antibodies :).